SOURCE: Blood Diagnostics, Inc.

May 19, 2008 17:22 ET

Blood Diagnostics, Inc. Awarded MedAssets Supply Chain Systems' Platinum Vendor Designation

IRMO, SC--(Marketwire - May 19, 2008) - Blood Diagnostics, Inc. (BDI) today announced it recently earned MedAssets Supply Chain Systems' Platinum Vendor status. The platinum level is the highest vendor designation awarded by MedAssets Supply Chain Systems, a MedAssets company (NASDAQ: MDAS). Blood Diagnostics, Inc. was awarded the Platinum Vendor designation at the MedAssets Healthcare Business Summit in Las Vegas in March 2008, attended by more than 3,000 healthcare professionals.

The award recognizes outstanding vendors and is based on improving customer savings and customer satisfaction, filing reports and submitting fee schedules in a timely manner, continuous growth in purchase volume, and supporting MedAssets' philanthropic efforts.

BDI is a specialty biopharmaceutical distributor that offers plasma-derivative pharmaceuticals such as IVIG (or intravenous immune globulin), hemophilia factor, albumin, hyper-immunes, and vaccines. As a fully Authorized Distributor of Record (ADR) with all of the major plasma-derivative manufacturers, BDI provides a safe and reliable source for products to MedAssets' members. "We are pleased to be awarded MedAssets Platinum Status, as this honor recognizes BDI's continued commitment to providing MedAssets' members with exceptional product supply solutions and unparalleled customer service," commented Hugh McLaurin, BDI's Director of Contracting.

About Blood Diagnostics, Inc.

Blood Diagnostics, Inc. (BDI) is a national specialty distributor of biopharmaceutical products. For more than a decade, the company has built an excellent reputation as an industry source for products and service. Serving the healthcare community since 1995, BDI has been committed to specialty biotherapeutics, immunologics and hemostatics, including Albumin (Human) USP, intravenous immune globulin (IVIG or IGIV), coagulation factors VIII, IX, and VIIa, as well as hyper-immunes, injectables and physician specialty pharmaceuticals. As a recognized Authorized Distributor of Record for the products it distributes, BDI is fully accredited and insured. BDI fulfills the licensing requirements in all 50 states. With distribution centers located on both coasts, BDI offers prompt shipping as well as emergency delivery service.

Emergency 24 / 7 availability, unparalleled customer service, and extensive product knowledge define BDI's customer-centric approach to serving the nation's healthcare community. The company serves as a free source for reference material and market data, offering healthcare providers the latest information on products, supply and other industry events. BDI's promotional literature and web site -- -- serve as open-access educational resources, contributing to the promotion of the biopharmaceutical industry and the education of both the healthcare community and general populace.

About MedAssets

MedAssets (NASDAQ: MDAS) partners with healthcare providers to improve their financial strength by implementing integrated spend management and revenue cycle solutions that help control cost, improve margins and cash flow, increase regulatory compliance, and optimize operational efficiency. MedAssets serves more than 125 health systems, 2,500 hospitals and 30,000 non-acute care healthcare providers. For more information, visit

Contact Information

  • For more information, please contact:
    Brad Davis
    Director of Marketing
    Blood Diagnostics, Inc.